Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment - Concepedia

Concepedia

Publication | Open Access

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment

DOI Full Paper Access

185

Citations

34

References

2019

Year

V. Deshmukh, Alyssa L. O'Green, Carine Bossard, T. Seo, L. Lamangan, Maureen Ibanez, A. Ghias, Carolyn Lai, Steven Cho, Joseph Cahiwat,

Osteoarthritis and Cartilage

References

	Year	Citations

Page 1